Indian firm Panacea says aiming to make COVID-19 vaccine

Panacea Biotec

10/06/2020 06:07

BENGALURU, June 10 (Reuters) - Indian biotech firm Panacea
Biotec Ltd  PNCA.NS  said on Wednesday it would partner with
U.S.-based Refana Inc to make a potential vaccine for COVID-19.
    The collaboration aims to make more than 500 million doses
of the vaccine candidate, with over 40 million doses expected to
be available early next year, Panacea said in a statement to
stock exchanges. (https://bit.ly/3dPPZQM)
    Panacea's shares jumped 20% in morning trading on India's
National Stock Exchange after the news.

 (Reporting by Sachin Ravikumar; Editing by Shailesh Kuber)
 ((saisachin.r@tr.com; +91 80 6182 2754; Twitter: @sachinr27;))